Search research articles
Contact Us
Filters
Showing results (171-180 of 193) with videos related to
Page
of 20
Sort By:
European Journal of Endocrinology
|
July 5, 2005
Efficacy of chimeric molecules directed towards multiple somatostatin and dopamine receptors on inhibition of GH and prolactin secretion from GH-secreting pituitary adenomas classified as partially responsive to somatostatin analog therapy
P Jaquet, G Gunz, A Saveanu, et al.
Journal of Endocrinological Investigation
|
April 22, 2006
BIM-23A760, a chimeric molecule directed towards somatostatin and dopamine receptors, vs universal somatostatin receptors ligands in GH-secreting pituitary adenomas partial responders to octreotide
P Jaquet, G Gunz, A Saveanu, et al.
La Nouvelle Presse Medicale
|
June 28, 1978
[A double-blind nomifensine-nortriptyline trial in ambulatory patients conducted by psychiatrists in private practice: results and comments]
J P Coudray, H Dufour, J L Garello, et al.
European Journal of Endocrinology
|
January 12, 2017
MRI follow-up is unnecessary in patients with macroprolactinomas and long-term normal prolactin levels on dopamine agonist treatment
J Eroukhmanoff, I Tejedor, I Potorac, et al.
L'Encephale
|
March 1, 1994
[7 years study of erythrocyte membrane transport of monoamine precursors. 395 patients (335 depressed, 60 schizophrenic patients)]
J M Azorin, P Bovier, P Chiaroni, et al.
L'Encephale
|
January 1, 1982
[Extensive multicentric study of 1354 cases of depressed subjects treated with amineptin]
P Deniker, G Besancon, L Colonna, et al.
Revue Neurologique
|
March 23, 2023
Innovative treatments for meningiomas
T Graillon, E Tabouret, B Salgues, et al.
European Journal of Endocrinology
|
December 22, 2000
Markers of tumor invasion are major predictive factors for the long-term outcome of corticotroph microadenomas treated by transsphenoidal adenomectomy
S Vallette-Kasic, H Dufour, M Mugnier, et al.
Journal of Neuroendocrinology
|
August 12, 1999
Expression of functional growth hormone secretagogue receptors in human pituitary adenomas: polymerase chain reaction, triple in-situ hybridization and cell culture studies
A Barlier, A J Zamora, M Grino, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
October 15, 1998
The hormonal response to stress is not modified by the dramatic decrease in prolactin plasma concentration during surgery for microprolactinoma
R Guieu, H Dufour, C Devaux, et al.
Page
of 20
Search research articles
Search
Showing results (171-180 of 193) with videos related to
Sort By:
Page
of 20
European Journal of Endocrinology
|
July 5, 2005
Efficacy of chimeric molecules directed towards multiple somatostatin and dopamine receptors on inhibition of GH and prolactin secretion from GH-secreting pituitary adenomas classified as partially responsive to somatostatin analog therapy
P Jaquet, G Gunz, A Saveanu, et al.
Journal of Endocrinological Investigation
|
April 22, 2006
BIM-23A760, a chimeric molecule directed towards somatostatin and dopamine receptors, vs universal somatostatin receptors ligands in GH-secreting pituitary adenomas partial responders to octreotide
P Jaquet, G Gunz, A Saveanu, et al.
La Nouvelle Presse Medicale
|
June 28, 1978
[A double-blind nomifensine-nortriptyline trial in ambulatory patients conducted by psychiatrists in private practice: results and comments]
J P Coudray, H Dufour, J L Garello, et al.
European Journal of Endocrinology
|
January 12, 2017
MRI follow-up is unnecessary in patients with macroprolactinomas and long-term normal prolactin levels on dopamine agonist treatment
J Eroukhmanoff, I Tejedor, I Potorac, et al.
L'Encephale
|
March 1, 1994
[7 years study of erythrocyte membrane transport of monoamine precursors. 395 patients (335 depressed, 60 schizophrenic patients)]
J M Azorin, P Bovier, P Chiaroni, et al.
L'Encephale
|
January 1, 1982
[Extensive multicentric study of 1354 cases of depressed subjects treated with amineptin]
P Deniker, G Besancon, L Colonna, et al.
Revue Neurologique
|
March 23, 2023
Innovative treatments for meningiomas
T Graillon, E Tabouret, B Salgues, et al.
European Journal of Endocrinology
|
December 22, 2000
Markers of tumor invasion are major predictive factors for the long-term outcome of corticotroph microadenomas treated by transsphenoidal adenomectomy
S Vallette-Kasic, H Dufour, M Mugnier, et al.
Journal of Neuroendocrinology
|
August 12, 1999
Expression of functional growth hormone secretagogue receptors in human pituitary adenomas: polymerase chain reaction, triple in-situ hybridization and cell culture studies
A Barlier, A J Zamora, M Grino, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
October 15, 1998
The hormonal response to stress is not modified by the dramatic decrease in prolactin plasma concentration during surgery for microprolactinoma
R Guieu, H Dufour, C Devaux, et al.
Page
of 20